Evaluation of the Clinical and Economic Impact of Pfizer's painPRIMER Program in the Treatment of Low Back Pain in a Primary Care Setting
Device Data
+ other Data
Collected from today forward - ProspectiveBack Pain+3
+ Neurologic Manifestations
+ Pain
Cohort
Tracking disease incidence in order to identify risk factors and understand disease progression over time.Summary
Study start date: June 1, 2013
Actual date on which the first participant was enrolled.To evaluate the impact of painPRIMER in a prospective six-month clinical investigation looking at clinical outcomes, health care professional and patient satisfaction, healthcare resource use, productivity and direct and indirect costs. The hypothesis is that early identification of the presence of neuropathic pain and back pain related comorbidities, to direct appropriate pharmacologic and non-pharmacologic treatment, painPRIMER would improve patient outcomes and reduce patient cycling, inappropriate use of imaging and surgery, thereby reducing costs and productivity loss associated with these inefficiencies.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.103 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Cohort
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Inclusion Criteria: Those aged 18 years of age Presenting to a HCP with low back pain Able to speak, write, and understand both verbal and written English Exclusion Criteria: Conditions that may impede the patient's ability to participate in painPRIMER and complete the questionnaires, as per the HCP's discretion Patients presenting who have undergone surgery for back pain in the previous 12 months Patients with Medicare as their primary insurance
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Pfizer Investigational Site
Fayetteville, United StatesOpen Pfizer Investigational Site in Google Maps